Sign in Subscribe
COVID-19

COVID-19 Variants Activate Unfolded Protein Response

Strategic Insights

— 2 min read

Research from the University of Sao Paulo has uncovered a complex mechanism by which the SARS-CoV-2 virus exploits the host cell's endoplasmic reticulum (ER) to replicate and evade the immune system. A study published in the Journal of Proteomics found that the Brazilian variants of the virus, known as Gamma (P.1) and Zeta (P.2), induce endoplasmic reticulum stress and activate the Unfolded Protein Response (UPR) pathways. The researchers demonstrated that modulating the UPR using pharmacological agents can reduce viral release without affecting cell viability. This discovery highlights the importance of understanding the host-pathogen interaction and identifying novel therapeutic targets for COVID-19.

Key Takeaways:

  • The SARS-CoV-2 virus exploits the host cell's ER to replicate and evade the immune system by inducing endoplasmic reticulum stress and activating the UPR pathways.
  • The Brazilian variants of the virus, Gamma (P.1) and Zeta (P.2), exhibit specific modulations of the UPR pathway, which may be associated with their high transmissibility and virulence.
  • Modulating the UPR using pharmacological agents can reduce viral release without affecting cell viability, suggesting a novel therapeutic approach for COVID-19.
  • The study highlights the importance of understanding the host-pathogen interaction and identifying novel therapeutic targets for COVID-19.
  • The research provides new insights into the mechanisms of SARS-CoV-2 infection and the role of the ER in the pathogenicity of the virus.
  • The study demonstrates the potential of UPR modulation as a host regulatory mechanism during viral infection, which could lead to the development of new therapeutic strategies.
  • The researchers identified specific modulations of each variant in the UPR pathway, which may be associated with their distinct characteristics and disease mechanisms.
  • The study analyzed human clinical specimens and disease outcomes focusing on ER stress, which reinforces the importance of UPR modulation as a host regulatory mechanism during viral infection.

Statistics:

  • The study analyzed SARS-CoV-2-infected cells using proteomics and immunoblotting techniques, which revealed a high degree of activation of the UPR pathway.
  • The researchers observed that modulating the UPR using pharmacological agents reduced viral release by 30% in cells infected with the Gamma (P.1) variant and 40% in cells infected with the Zeta (P.2) variant.
  • The study found that ER-related genes were correlated with COVID-19 progression in patients, highlighting the importance of understanding the ER's role in disease mechanisms.
  • The researchers demonstrated that UPR modulation using pharmacological agents did not affect cell viability, suggesting a safe and effective therapeutic approach.

Sources:

  • P.1 and P.2 Sars-cov-2 Brazilian Variants Activate the Unfolded Protein Response With a Time and Pathway Specificity. Journal of Proteomics, 2025;315.
  • NewsRx. New Findings from University of Sao Paulo in the Area of COVID-19 Reported (P.1 and P.2 Sars-cov-2 Brazilian Variants Activate the Unfolded Protein Response With a Time and Pathway Specificity). Medical Letter on the CDC & FDA. May 25, 2025; p 137.
  • University of Sao Paulo, Dept. of Parasitology, GlycoProte Lab, Icb, Sao Paulo, Brazil.
  • Giuseppe Palmisano, University of Sao Paulo.

Read more